92 related articles for article (PubMed ID: 17554124)
21. Amyloidosis: a familiar problem in the light of current pathogenetic developments.
Kisilevsky R
Lab Invest; 1983 Oct; 49(4):381-90. PubMed ID: 6353059
[No Abstract] [Full Text] [Related]
22. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic options in systemic AL amyloidosis.
van Gameren II; Lokhorst H; Hazenberg BP; Vellenga E
Neth J Med; 2004 Apr; 62(4):106-13. PubMed ID: 15255079
[TBL] [Abstract][Full Text] [Related]
24. [Amyloid neuropathies. Histopathological study of peripheral nerve biopsy in 18 cases].
Bouillot S; Vital A; Favereaux A; Ferrer X; Lagueny A; Vital C
Ann Pathol; 2003 Apr; 23(2):114-20. PubMed ID: 12843966
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.
Gottenberg JE; Merle-Vincent F; Bentaberry F; Allanore Y; Berenbaum F; Fautrel B; Combe B; Durbach A; Sibilia J; Dougados M; Mariette X
Arthritis Rheum; 2003 Jul; 48(7):2019-24. PubMed ID: 12847696
[TBL] [Abstract][Full Text] [Related]
26. Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits.
Rekhtman N; Hash KS; Moresi JM
Br J Dermatol; 2006 Apr; 154(4):751-4. PubMed ID: 16536823
[TBL] [Abstract][Full Text] [Related]
27. Systemic amyloidosis: a review with emphasis on pathogenesis.
Westermark P; Johnson KH; Pitkänen P
Appl Pathol; 1985; 3(1-2):55-68. PubMed ID: 3939490
[TBL] [Abstract][Full Text] [Related]
28. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
Husby G; Sletten K; Blumenkrantz N; Danielsen L
Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
[TBL] [Abstract][Full Text] [Related]
29. [Immunoglobulin amyloidosis].
Hermine O; Bourquelot P; Buzyn A; Aucouturier P
Rev Prat; 1997 Oct; 47(16):1787-91. PubMed ID: 9453204
[TBL] [Abstract][Full Text] [Related]
30. Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).
Glenner GG
N Engl J Med; 1980 Jun; 302(23):1283-92. PubMed ID: 6154243
[No Abstract] [Full Text] [Related]
31. Localized amyloidosis of the seminal vesicle. Possible association with hormonally treated prostatic adenocarcinoma.
Unger PD; Wang Q; Gordon RE; Stock R; Stone N
Arch Pathol Lab Med; 1997 Dec; 121(12):1265-8. PubMed ID: 9431316
[TBL] [Abstract][Full Text] [Related]
32. Light-chain (AL) amyloidosis: diagnosis and treatment.
Sanchorawala V
Clin J Am Soc Nephrol; 2006 Nov; 1(6):1331-41. PubMed ID: 17699366
[TBL] [Abstract][Full Text] [Related]
33. [Is the approach to therapy of AL-amyloidosis changing--editorial].
Elbl L
Vnitr Lek; 2013 Feb; 59(2):96-8. PubMed ID: 23599969
[No Abstract] [Full Text] [Related]
34. [Advances in treatment of light chains amyloidosis: an overview].
Pluta A; Dudziński M; Pluta A; Starzak-Gwóźdź J
Pol Arch Med Wewn; 1999 Nov; 102(5):1001-7. PubMed ID: 11072536
[No Abstract] [Full Text] [Related]
35. Familial mutations in fibrinogen Aα (FGA) chain identified in renal amyloidosis increase in vitro amyloidogenicity of FGA fragment.
Sivalingam V; Patel BK
Biochimie; 2016 Aug; 127():44-9. PubMed ID: 27126074
[TBL] [Abstract][Full Text] [Related]
36. Immunoglobulin light chain amyloidosis.
Merlini G; Comenzo RL; Seldin DC; Wechalekar A; Gertz MA
Expert Rev Hematol; 2014 Feb; 7(1):143-56. PubMed ID: 24350907
[TBL] [Abstract][Full Text] [Related]
37. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.
Said SM; Sethi S; Valeri AM; Leung N; Cornell LD; Fidler ME; Herrera Hernandez L; Vrana JA; Theis JD; Quint PS; Dogan A; Nasr SH
Clin J Am Soc Nephrol; 2013 Sep; 8(9):1515-23. PubMed ID: 23704299
[TBL] [Abstract][Full Text] [Related]
38. β(2)-microglobulin amyloidosis.
Corlin DB; Heegaard NH
Subcell Biochem; 2012; 65():517-40. PubMed ID: 23225015
[TBL] [Abstract][Full Text] [Related]
39. Out-of-register β-sheets suggest a pathway to toxic amyloid aggregates.
Liu C; Zhao M; Jiang L; Cheng PN; Park J; Sawaya MR; Pensalfini A; Gou D; Berk AJ; Glabe CG; Nowick J; Eisenberg D
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20913-8. PubMed ID: 23213214
[TBL] [Abstract][Full Text] [Related]
40. Amyloidogenesis in its biological environment: challenging a fundamental issue in protein misfolding diseases.
Bellotti V; Chiti F
Curr Opin Struct Biol; 2008 Dec; 18(6):771-9. PubMed ID: 18952166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
